Umb Bank, N.A. Adma Biologics, Inc. Transaction History
Umb Bank, N.A.
- $6.3 Billion
- Q3 2024
A detailed history of Umb Bank, N.A. transactions in Adma Biologics, Inc. stock. As of the latest transaction made, Umb Bank, N.A. holds 481 shares of ADMA stock, worth $8,797. This represents 0.0% of its overall portfolio holdings.
Number of Shares
481Holding current value
$8,797% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding ADMA
# of Institutions
318Shares Held
184MCall Options Held
917KPut Options Held
91.6K-
Black Rock Inc. New York, NY18.6MShares$341 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA18.1MShares$331 Million0.01% of portfolio
-
State Street Corp Boston, MA13MShares$238 Million0.01% of portfolio
-
Invesco Ltd. Atlanta, GA12.6MShares$231 Million0.05% of portfolio
-
Morgan Stanley New York, NY8.6MShares$157 Million0.01% of portfolio
About ADMA BIOLOGICS, INC.
- Ticker ADMA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 196,356,992
- Market Cap $3.59B
- Description
- ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...